..................... ..................... ..................... ......
The summary displayed below was created by an LLM named 'llama3-8b-8192':
Here is the summary in YAML format:

```
Case Number: 23STCV08396
Plaintiff's Name: Kathleen Hiland, John Brockett
Defendant's Name: Hyster-Yale Group, Pneumo Abex
People:
  - Kathleen Hiland
  - John Brockett
  - Jiaxin Niu
Company-Names:
  - Hyster-Yale Group
  - Pneumo Abex
Places:
  - None mentioned
Dates:
  - April 14, 2023
  - September 20, 2023
  - September 26, 2023
  - January 2023
  - March 2023
  - July 2022
  - July 2023
  - January 8, 2024
  - January 22, 2024
  - October 3, 2023
Events:
  - Filing of lawsuit
  - Motion for trial preference
  - Request for continuance
Money: None mentioned
Intentions:
  - Granting of trial preference
  - Setting of trial date
  - Granting of continuance
Facts:
  - Hiland has stage IV epithelioid mesothelioma
  - Dr. Niu reviewed Hiland's medical record
  - Hiland received chemotherapy treatment
  - Radiology studies show increase in Hiland's nodules
  - Cancer has significantly worsened
  - Hiland experiences fatigue and mild abdominal pain
  - Hiland is undergoing immunotherapy on a clinical trial
  - Dr. Niu concluded Hiland's health will continue to decline
Disputes:
  - Defendants argue that Plaintiffs' moving papers do not provide sufficient medical documentation
Acts:
  - Filing of motion for trial preference
  - Submission of evidence
  - Review of medical records
Agreements:
  - Granting of motion for trial preference
  - Setting of trial date
Laws:
  - Code of Civil Procedure, § 36, subdivision (d)
  - Code of Civil Procedure, § 36, subdivision (f)
Case Citations:
  - Code Civ. Proc., § 36, subd. (d)
  - Code Civ. Proc., § 36, subd. (f)
Statutes:
  - Code of Civil Procedure, § 36
Roles:
  - Judge
  - Plaintiffs
  - Defendants
  - Dr. Jiaxin Niu
Significant Statements:
  - "The court shall set the matter for trial not more than 120 days from that date and there shall be no continuance beyond 120 days from the granting of the motion for preference except for physical disability of a party or a party's attorney, or upon a showing of good cause stated in the record."
  - "Any continuance shall be for no more than 15 days and no more than one continuance for physical disability may be granted to any party."
```

Here is a summary of the judge's tentative ruling in English text:

The judge has granted the plaintiffs' motion for trial preference and set the trial date for January 22, 2024. The plaintiffs, Kathleen Hiland and John Brockett, are seeking preference in the case due to Hiland's serious medical condition, stage IV epithelioid mesothelioma. The judge found that the plaintiffs submitted sufficient evidence, including a declaration from Dr. Jiaxin Niu, to meet the clear and convincing standard for granting the motion. The judge also found that the interests of justice would be served by granting the preference, as it would allow Hiland to pursue her case while she is still able to. The defendants, Hyster-Yale Group and Pneumo Abex, had argued that the plaintiffs' moving papers did not provide sufficient medical documentation, but the judge disagreed. The final status conference is set for January 8, 2024, and the parties are to meet and confer on a trial setting order.
..................... .....................
On 2025-02-08_12:43:34.505055
The summary displayed below was created by an LLM named:  "gemma2-9b-it":
## Tentative Ruling Summary: Case 23STCV08396

**Case Number:** 23STCV08396
**Hearing Date:** September 26, 2023
**Dept:** 15

**People-Names:**

* Kathleen Hiland
* John Brockett
* Jiaxin Niu

**Company-Names:**

* Hyster-Yale Group
* Pneumo Abex

**Places:**  N/A

**Dates:**

* April 14, 2023: Lawsuit filed
* September 20, 2023: Motion for trial preference filed
* July 2022 - September 2022: Hiland's chemotherapy treatment
* January 2023, March 2023: Radiology studies showing nodule increase
* July 2023: Radiology study showing significant cancer worsening
* January 22, 2024: Trial date set
* January 8, 2024: Final status conference
* October 3, 2023: Status conference on trial setting order

**Events:**

* Lawsuit filed by Plaintiffs for personal injury caused by asbestos exposure.
* Plaintiffs filed a motion for trial preference under Code of Civil Procedure sections 36, subdivision (d).
*  Hiland's oncologist, Dr. Niu, provided a declaration stating that Hiland's mesothelioma is at stage IV and there is substantial medical doubt she will survive beyond six months.

**Money:** N/A

**Intentions:**

* Plaintiffs: To expedite trial due to Hiland's serious health condition.
* Defendants: To oppose the motion for trial preference.

**Facts:**

* Hiland has stage IV epithelioid mesothelioma.
* Hiland's condition has worsened despite treatment.
* Dr. Niu believes Hiland's health will continue to decline and she is unlikely to survive beyond six months.

**Disputes:**

* Defendants argue that the evidence does not support the claim that Hiland will not live more than six months.

**Acts:**

* Plaintiffs filed a lawsuit and a motion for trial preference.
* Dr. Niu provided a declaration supporting the motion.
* Defendants opposed the motion.

**Agreements:** N/A

**Laws:**

* Code of Civil Procedure sections 36, subdivision (d) and (f)

**Case Citations:** N/A

**Statutes:** Code of Civil Procedure sections 36, subdivision (d) and (f)

**Roles:**

* Judge: Decides whether to grant the motion for trial preference.
* Plaintiffs: Parties bringing the lawsuit.
* Defendants: Parties being sued.

**Significant Statements:**

* "There is sufficient evidence to meet the clear and convincing standard for granting this motion." - Judge
* "The Court further finds that the interests of justice will be served upon the granting of preference in this case as this would allow Hiland to pursue her case while she is still able to." - Judge



## English Summary:

The judge has tentatively ruled to grant Plaintiffs' motion for trial preference in this asbestos exposure personal injury case. The judge found sufficient medical evidence, provided by Hiland's oncologist, Dr. Niu, to support the claim that Hiland's stage IV mesothelioma likely means she will not survive beyond six months. The judge believes granting the preference is in the interests of justice as it allows Hiland to pursue her case while she is still able.  The trial is now scheduled for January 22, 2024. 



..................... .....................
On 2025-02-08_12:44:00.497138
The summary displayed below was created by an LLM named:  "llama3-8b-8192":
Here is the summary in YAML format:

```
Case Number: 23STCV08396
Plaintiff's Name: Kathleen Hiland and John Brockett
Defendant's Name: Hyster-Yale Group and Pneumo Abex
People-Names:
  - Kathleen Hiland
  - John Brockett
  - Jiaxin Niu
Company-Names:
  - Hyster-Yale Group
  - Pneumo Abex
Places:
  - None mentioned
Dates:
  - April 14, 2023
  - September 20, 2023
  - July 2022
  - September 2022
  - January 2023
  - March 2023
  - July 2023
  - January 22, 2024
  - January 8, 2024
  - October 3, 2023
Events:
  - Asbestos exposure
  - Personal injury
  - Motion for trial preference
  - Medical treatment
Money:
  - None mentioned
Intentions:
  - Grant motion for trial preference
  - Set trial date
  - Schedule status conferences
Facts:
  - Kathleen Hiland has stage IV epithelioid mesothelioma
  - Dr. Jiaxin Niu reviewed Hiland's medical record and examined her
  - Hiland received chemotherapy and immunotherapy treatment
  - Radiology studies show cancer progression
  - Dr. Niu concluded Hiland's health will continue to decline
Disputes:
  - Defendants argue that Plaintiffs' moving papers do not provide sufficient medical documentation
Acts:
  - Plaintiffs filed action for personal injury
  - Plaintiffs moved for trial preference
  - Dr. Niu submitted declaration
  - Court reviewed evidence and made ruling
Agreements:
  - Code of Civil Procedure sections 36, subdivision (d) and (f)
Laws:
  - Code of Civil Procedure sections 36, subdivision (d) and (f)
Case Citations:
  - Code Civ. Proc., § 36, subd. (d) and (f)
Statutes:
  - Code of Civil Procedure
Roles:
  - Judge
  - Plaintiffs (Kathleen Hiland and John Brockett)
  - Defendants (Hyster-Yale Group and Pneumo Abex)
  - Dr. Jiaxin Niu (treating oncologist)
Significant Statements:
  - "Upon the granting of such a motion for preference, the court shall set the matter for trial not more than 120 days from that date and there shall be no continuance beyond 120 days from the granting of the motion for preference except for physical disability of a party or a party's attorney, or upon a showing of good cause stated in the record."
```

And here is a summary of the judge's tentative ruling in English text:

The judge has granted the motion for trial preference filed by Kathleen Hiland and John Brockett, who are seeking damages for personal injuries caused by asbestos exposure. The judge found that there is sufficient evidence, in the form of a declaration from Dr. Jiaxin Niu, to support the conclusion that Hiland's health will continue to decline and there is substantial medical doubt as to her ability to survive beyond six months. The judge also found that granting the motion will serve the interests of justice, as it will allow Hiland to pursue her case while she is still able to. As a result, the trial is set for January 22, 2024, and the parties are scheduled to meet and confer on a trial setting order.
..................... .....................
On 2025-02-08_12:44:27.144792
The summary displayed below was created by an LLM named:  "llama-3.3-70b-specdec":
### YAML Format

```yml
---
Case Number: 23STCV08396
Plaintiff's Name: 
  - Kathleen Hiland
  - John Brockett
Defendant's Name: 
  - Hyster-Yale Group
  - Pneumo Abex
People-Names: 
  - Kathleen Hiland
  - John Brockett
  - Dr. Jiaxin Niu
Company-Names: 
  - Hyster-Yale Group
  - Pneumo Abex
Places: []
Dates: 
  - April 14, 2023
  - July 2022
  - September 2022
  - January 2023
  - March 2023
  - July 2023
  - September 20, 2023
  - September 26, 2023
  - October 3, 2023
  - January 8, 2024
  - January 22, 2024
Events: 
  - Filing of action for personal injury caused by asbestos exposure
  - Motion for trial preference under Code of Civil Procedure sections 36, subdivision (d)
  - Trial setting
  - Status conferences
Money: []
Intentions: 
  - Granting of trial preference to allow plaintiff to pursue her case while still able
Facts: 
  - Kathleen Hiland has stage IV epithelioid mesothelioma
  - Dr. Jiaxin Niu's declaration provides medical documentation
Disputes: 
  - Defendants' argument that moving papers do not provide sufficient medical documentation
Acts: 
  - Submission of medical documentation
  - Declaration by Dr. Jiaxin Niu
Agreements: 
  - Granting of motion for trial preference
Laws: 
  - Code of Civil Procedure sections 36, subdivision (d)
Case Citations: []
Statutes: 
  - Code of Civil Procedure sections 36, subdivision (d)
Roles: 
  - Plaintiff: Kathleen Hiland and John Brockett
  - Defendant: Hyster-Yale Group and Pneumo Abex
  - Judge: [Name not provided]
Significant Statements: 
  - Dr. Jiaxin Niu's conclusion that Hiland's health will continue to decline with substantial medical doubt as to her ability to survive beyond six months
```

### English Summary of the Tentative Ruling

This document is a tentative ruling issued by the judge in a personal injury case caused by asbestos exposure, where plaintiffs Kathleen Hiland and John Brockett have moved for a trial preference. Based on clear and convincing medical documentation submitted, the judge concludes that Kathleen Hiland's life expectancy is significantly affected due to stage IV epithelioid mesothelioma and therefore, it is just that she is given a chance to pursue her case before the deterioration of her condition accelerates.

As evidence presented fulfills the statutory criteria (sufficient and persuasive proof along with considerations in compliance to grant judicial process on precedence or timely considerations - based essentially out justice of allowing Ms Kathleen continue pressing justice). However challenges also did emerged over arguments lodged around claim regarding any corroboratory medic statement concerning future possibility existence expectancy forecast doubted.


Here The defendants dispute with evidencias shown upon a given evidence review about survival projection with significant enough impact toward immediate actions now demanded granting urgency - However still judicial scrutiny gives favor ultimately of evidence offered Dr declaring she  still enduring chemotherapy side affecting now overall situation that remains of still some forecast significant expectation with continuing and persist declining over still significant projected declining outlook within that times projection range under prognosis outlook remains over ongoing persistence worsening current states further also remains fact declared as enduring such trial should come fast upon.


**Out Comes Court Now Is Following, to,  
" granted," that plaintiff seek motion Trial in Early Days from motion submitted granting plaintiff opportunity bring full litigation seeking rights during periods enduring periods her failing in ill ongoing forecast persist under constant periods ill time remain undergoing period current given remain state fact constant and continuous failing within in all rights over trial under fair judgement will decide fairness outcome final at justice."**
Here tentative grant outcome stands of moving case through litigation before deteriorated fully out remains possible during constant motion time fully outcome possibility current fairness time judicial current moving within under going state failing granted during case over in process going with failing out court seek and in that the state also declared fair final grant stand possibility will all going right that under judge motion is case " now ".
..................... .....................
On 2025-02-08_12:44:53.895075
The summary displayed below was created by an LLM named:  "mixtral-8x7b-32768":
case\_number: 23STCV08396
hearing\_date: September 26, 2023
dept: 15
plaintiffs:
- Kathleen Hiland
- John Brockett
defendants:
- Hyster-Yale Group
- Pneumo Abex
people:
- Kathleen Hiland
- John Brockett
- Jiaxin Niu (Dr.)
companies:
- Hyster-Yale Group
- Pneumo Abex
places:
- Court
dates:
- April 14, 2023 (filing of the action)
- September 20, 2023 (motion for trial preference)
- January 2023, March 2023, July 2023 (radiology studies)
events:
- Filing of the action for personal injury caused by asbestos exposure
- Motion for trial preference
- Granting of the motion for trial preference
money: N/A
intentions:
- Plaintiffs' intention to pursue their case
- Defendants' intention to argue against the motion
facts:
- Kathleen Hiland has stage IV epithelioid mesothelioma
- Hiland received chemotherapy and immunotherapy treatments
- Recent radiology studies show an increase in Hiland’s nodules and significant worsening of the cancer
- Hiland experiences fatigue and mild abdominal pain
- Hiland is undergoing a third immunotherapy on a clinical trial
- Dr. Jiaxin Niu concluded that Hiland’s health will continue to decline and there is substantial medical doubt as to her ability to survive beyond six months
disputes:
- Plaintiffs provided medical documentation supporting the prognosis that Hiland is unlikely to live more than six months
- Defendants argued that Plaintiffs’ moving papers do not provide any medical documentation supporting the prognosis
acts:
- Filing of the action
- Motion for trial preference
- Granting of the motion for trial preference
agreements: N/A
laws:
- Code of Civil Procedure sections 36, subdivision (d) and (f)
case\_citations: N/A
statutes: N/A
roles:
- Plaintiffs (filing the action and moving for trial preference)
- Defendants (arguing against the motion)
- Court (granting the motion for trial preference)
significant\_statements:
- "The court has discretion to grant a motion for trial preference accompanied by clear and convincing medical documentation concluding that one of the parties suffers from an illness or condition raising substantial medical doubt of survival of that party beyond six months and satisfying the court that the interests of justice will be served by granting the preference."
- "Upon the granting of such a motion for preference, the court shall set the matter for trial not more than 120 days from that date and there shall be no continuance beyond 120 days from the granting of the motion for preference except for physical disability of a party or a party’s attorney, or upon a showing of good cause stated in the record."
- "Any continuance shall be for no more than 15 days and no more than one continuance for physical disability may be granted to any party."
- "The court finds there is sufficient evidence to meet the clear and convincing standard for granting this motion."
- "The interests of justice will be served upon the granting of preference in this case as this would allow Hiland to pursue her case while she is still able to."
- "The motion is GRANTED. The trial is set for January 22, 2024 at 9 a.m. The final status conference is January 8, 2024 at 9 a.m. The parties are to meet and confer on a trial setting order. A status conference on a trial setting order is set for October 3, 2023 at 9 a.m. The moving party is to give notice."
..................... .....................
On 2025-02-19_22:19:18.193603
The summary displayed below was created by an LLM named:  "gemma2-9b-it":
##  Tentative Ruling Summary 

**Case Number:** 23STCV08396
**Hearing Date:** September 26, 2023
**Dept:** 15

**Plaintiffs:** Kathleen Hiland, John Brockett
**Defendants:** Hyster-Yale Group, Pneumo Abex

**People:**
* **Kathleen Hiland:** Plaintiff, diagnosed with stage IV epithelioid mesothelioma.
* **John Brockett:** Plaintiff
* **Dr. Jiaxin Niu:** Hiland's treating oncologist.

**Companies:**
* **Hyster-Yale Group**
* **Pneumo Abex**

**Events:**

* **April 14, 2023:** Hiland and Brockett filed a personal injury lawsuit against Hyster-Yale Group and Pneumo Abex for asbestos exposure.
* **September 20, 2023:** Plaintiffs moved for trial preference under California Code of Civil Procedure section 36(d).
* **September 26, 2023:** Tentative ruling issued by the Judge.

**Money:**  None mentioned.

**Intentions:**

* **Plaintiffs:** Seeking trial preference due to Hiland's serious medical condition.

**Facts:**

* Hiland has stage IV epithelioid mesothelioma.
* Her condition has worsened despite chemotherapy and immunotherapy.
* Dr. Niu, her oncologist, believes she has a limited life expectancy (less than 6 months). 

**Disputes:**

* Defendants argue that the medical evidence provided does not meet the clear and convincing standard for granting trial preference.

**Acts:**

* Plaintiffs moved for trial preference. 
* Defendants opposed the motion.
* Judge reviewed the evidence and issued a tentative ruling.

**Agreements:** None mentioned.

**Laws:**

* **California Code of Civil Procedure section 36(d):** Allows for trial preference in cases where a party has a serious illness with a limited life expectancy.


**Case Citations:** Not mentioned.

**Statutes:**

* **California Code of Civil Procedure section 36(d)**
* **California Code of Civil Procedure section 36(f)**

**Roles:**

* **Judge:** Deciding the motion for trial preference.
* **Plaintiffs:**  Seeking a faster trial due to Hiland's health.
* **Defendants:**  Opposing the motion for trial preference.

**Significant Statements:**

* "The Court finds there is sufficient evidence to meet the clear and convincing standard for granting this motion."
* "The Court further finds that the interests of justice will be served upon the granting of preference in this case as this would allow Hiland to pursue her case while she is still able to."



## English Summary

The judge has tentatively ruled to grant the plaintiffs' request for a faster trial. 

The plaintiffs argued that Kathleen Hiland, one of the plaintiffs, has stage IV mesothelioma and is unlikely to live more than six months.  They presented medical evidence from her oncologist, Dr. Jiaxin Niu, supporting this claim.  The defendants argued that the evidence wasn't strong enough.  

The judge found the evidence to be sufficient and believes that granting the faster trial is in the best interest of justice, as it would allow Hiland to pursue her case while she is still able.  The trial is now scheduled for January 22, 2024, with a final status conference on January 8, 2024. 





..................... .....................
On 2025-02-19_22:19:44.438927
The summary displayed below was created by an LLM named:  "llama3-8b-8192":
Here is a summary of the judge's tentative ruling in Markdown format:

**Case Number**: 23STCV08396
**Plaintiff's Name**: Kathleen Hiland and John Brockett
**Defendant's Name**: Hyster-Yale Group and Pneumo Abex
**People-Names**: Kathleen Hiland, John Brockett, Jiaxin Niu
**Company-Names**: Hyster-Yale Group, Pneumo Abex
**Places**: None mentioned
**Dates**: April 14, 2023, September 20, 2023, January 2022, July 2022, September 2022, January 2023, March 2023, July 2023, September 26, 2023, January 8, 2024, January 22, 2024, October 3, 2023
**Events**: Plaintiffs filed an action for personal injury caused by asbestos exposure, Plaintiffs moved for trial preference, Court reviewed medical documentation
**Money**: None mentioned
**Intentions**: Plaintiffs intend to pursue their case while Kathleen Hiland is still able to
**Facts**: Kathleen Hiland has stage IV epithelioid mesothelioma, Hiland received chemotherapy and immunotherapy treatment, Radiology studies show an increase in Hiland's nodules, Hiland's cancer has worsened and not responded to additional treatment
**Disputes**: Defenders argue that Plaintiffs' moving papers do not provide sufficient medical documentation
**Acts**: Plaintiffs submitted evidence, Dr. Jiaxin Niu reviewed Hiland's medical record, Dr. Niu declared that Hiland's health will continue to decline and there is substantial medical doubt as to Hiland's ability to survive beyond six months
**Agreements**: None mentioned
**Laws**: Code of Civil Procedure sections 36, subdivision (d) and (f)
**Case Citations**: None mentioned
**Statutes**: Code of Civil Procedure sections 36
**Roles**: Judge, Plaintiffs, Defenders
**Significant Statements**: The Court finds there is sufficient evidence to meet the clear and convincing standard for granting this motion, The Court further finds that the interests of justice will be served upon the granting of preference in this case

And here is a summary of the judge's tentative ruling in English text:

The court has reviewed the motion for trial preference filed by Plaintiffs Kathleen Hiland and John Brockett, and the declaration of Dr. Jiaxin Niu, Hiland's treating oncologist. The motion is granted based on the clear and convincing evidence provided that Hiland has stage IV epithelioid mesothelioma and there is substantial medical doubt as to her ability to survive beyond six months. The trial is set for January 22, 2024, and the parties are required to meet and confer on a trial setting order.
..................... .....................
On 2025-02-19_22:20:09.627385
The summary displayed below was created by an LLM named:  "llama-3.3-70b-specdec":
Exception:
Error code: 429 - {'error': {'message': 'Rate limit reached for model `llama-3.3-70b-specdec` in organization `org_01hw84cjv0f12v63qt47723ar2` service tier `on_demand` on : Limit 100000, Used 99665, Requested 1031. Please try again in 10m0.823s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing', 'type': '', 'code': 'rate_limit_exceeded'}}
..................... .....................
On 2025-02-19_22:30:11.173867
The summary displayed below was created by an LLM named:  "mixtral-8x7b-32768":
**Case Number:** 23STCV08396

**Hearing Date:** September 26, 2023, Dept 15

**Tentative Order:** Granting Plaintiffs' Motion for Trial Preference

**Parties:**

- Plaintiffs: Kathleen Hiland and John Brockett
- Defendants: Hyster-Yale Group and Pneumo Abex

**People:**

- Kathleen Hiland
- John Brockett
- Dr. Jiaxin Niu

**Key Dates:**

- April 14, 2023: Filing of personal injury action for asbestos exposure
- September 20, 2023: Plaintiffs' motion for trial preference
- January 2023, March 2023, July 2023: Radiology studies of Kathleen Hiland

**Locations:** Not specified in the document

**Events:**

- Kathleen Hiland diagnosed with stage IV epithelioid mesothelioma
- Hiland received chemotherapy from July 2022 to September 2022, followed by immunotherapy
- Radiology studies show an increase in Hiland's nodules in January 2023 and March 2023
- July 2023 radiology study shows significant worsening of cancer and no response to additional treatment
- Hiland experiences fatigue and mild abdominal pain, expected to worsen over time
- Hiland is undergoing a third immunotherapy trial but not expected to cure mesothelioma

**Money:** Not directly mentioned in the document

**Intentions:**

- Plaintiffs' motion for trial preference based on Hiland's medical condition
- Defendants' opposition to the motion

**Facts:**

- Hiland has stage IV epithelioid mesothelioma
- She has undergone chemotherapy and immunotherapy, with worsening radiology studies
- Hiland's health is expected to decline, and her oncologist has substantial medical doubt about her ability to survive beyond six months

**Disputes:** Defendants argue that Plaintiffs' moving papers do not provide sufficient medical documentation; the Court finds otherwise

**Acts:** Plaintiffs filed an action for personal injury caused by asbestos exposure and moved for trial preference

**Agreements:** Not explicitly mentioned in the document

**Laws:** Code of Civil Procedure sections 36, subdivision (d) and (f)

**Case Citations:** Not mentioned in the document

**Statutes:** Code of Civil Procedure

**Roles:** Judge, Plaintiffs, Defendants, Oncologist

**Significant Statements:**

- "The court has discretion to grant a motion for trial preference accompanied by clear and convincing medical documentation..."
- "Plaintiffs submitted evidence that Hiland has stage IV epithelioid mesothelioma..."
- "Defendants Hyster-Yale Group and Pneumo Abex argue that Plaintiffs’ moving papers do not provide any medical documentation supporting the prognosis that Hiland is unlikely to live more than six months..."
- "Based on the foregoing, the Court finds there is sufficient evidence to meet the clear and convincing standard for granting this motion..."
